Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

2017-10-11
Price :
Published : Oct-2017
No. of Pages : 292
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Hepatitis Viruses Diagnostic Tests Overview 13
3 Products under Development 14
3.1 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Stage of Development 14
3.2 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Territory 15
3.3 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Regulatory Path 16
3.4 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Estimated Approval Date 17
3.5 Hepatitis Viruses Diagnostic Tests - Ongoing Clinical Trials 18
4 Hepatitis Viruses Diagnostic Tests - Pipeline Products under Development by Companies 19
4.1 Hepatitis Viruses Diagnostic Tests Companies - Pipeline Products by Stage of Development 19
4.2 Hepatitis Viruses Diagnostic Tests - Pipeline Products by Stage of Development 22
5 Hepatitis Viruses Diagnostic Tests Companies and Product Overview 26
5.1 Abbott Diagnostics Company Overview 26
5.2 Access Bio Inc Company Overview 29
5.3 Alderon Biosciences, Inc. Company Overview 30
5.4 Alere Inc Company Overview 31
5.5 Aptus Biotech SL Company Overview 32
5.6 AutoGenomics Inc Company Overview 33
5.7 AXO Science SAS Company Overview 35
5.8 BCR Corp Company Overview 36
5.9 Beckman Coulter Inc Company Overview 37
5.10 Biokit SA Company Overview 42
5.11 Biomagnetics Diagnostics Corporation Company Overview 45
5.12 Bio-Rad Laboratories Inc Company Overview 46
5.13 Boditech Med Inc Company Overview 48
5.14 CeMines, Inc. (Inactive) Company Overview 52
5.15 Cepheid Company Overview 53
5.16 China Medical Technologies Inc (Inactive) Company Overview 55
5.17 Co-Diagnostics HBDC, Inc. Company Overview 56
5.18 Corgenix Medical Corp Company Overview 57
5.19 Da An Gene Co Ltd Company Overview 58
5.20 Diagnostics for the Real World (Europe) Ltd. Company Overview 61
5.21 DiaSorin S.p.A Company Overview 62
5.22 D-Kimia, LLC. Company Overview 67
5.23 DNAE Group Holdings Ltd Company Overview 68
5.24 Ecoli s.r.o. Company Overview 69
5.25 Enzo Biochem Inc Company Overview 80
5.26 Fast-track diagnostics S.a.r.l. Company Overview 81
5.27 Ferrer inCode SL Company Overview 83
5.28 French National Institute of Health and Medical Research Company Overview 84
5.29 Genera Biosystems Ltd Company Overview 85
5.30 Genome Diagnostics Pvt. Ltd. Company Overview 86
5.31 Goodgene Inc Company Overview 87
5.32 Hologic Inc Company Overview 89
5.33 LifeAssay Diagnostics (Pty) Ltd Company Overview 92
5.34 MedMira Inc. Company Overview 94
5.35 Mindray Medical International Ltd Company Overview 95
5.36 MND Diagnostic LTD Company Overview 104
5.37 NanoDiagX Company Overview 105
5.38 OPKO Health Inc Company Overview 106
5.39 Orangelife Company Overview 108
5.40 Paramedical Srl Company Overview 109
5.41 Pathogenica Inc Company Overview 115
5.42 ProteinLogic Ltd Company Overview 116
5.43 Qiagen NV Company Overview 117
5.44 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 119
5.45 Roche Diagnostics International Ltd Company Overview 120
5.46 Sansure Biotech Inc Company Overview 127
5.47 Siemens Healthcare GmbH Company Overview 130
5.48 Stanford University Company Overview 135
5.49 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 136
5.50 Sysmex Corp Company Overview 138
5.51 The Pennsylvania State University Company Overview 140
5.52 University Medical Center Hamburg-Eppendorf Company Overview 141
5.53 University of British Columbia Company Overview 142
5.54 University of Texas Medical Branch at Galveston Company Overview 143
5.55 University of Warwick Company Overview 144
5.56 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview 145
5.57 Xiamen Zeesan Biotech Co.,Ltd Company Overview 146
6 Hepatitis Viruses Diagnostic Tests - Recent Developments 147
6.1 Sep 20, 2017: Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis 147
6.2 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma 148
6.3 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 148
6.4 Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories 149
6.5 Aug 30, 2017: bioMerieux - First-Half 2017 Results 149
6.6 Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 153
6.7 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 153
6.8 Aug 17, 2017: TATAA Biocenter Expands Its Real-Time PCR Offerings With Analytik Jena's qTOWER3 154
6.9 Aug 09, 2017: Trovagene Announces Second Quarter 2017 Company Highlights and Financial Results 155
6.10 Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results 156
6.11 Aug 07, 2017: Quotient Reports Results From Ongoing MosaiQ Performance Evaluation Studies and First Quarter Fiscal 2018 Financial Results 158
6.12 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 160
6.13 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 160
6.14 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 161
6.15 Aug 02, 2017: OraSure Announces 2017 Second Quarter Financial Results 165
6.16 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 167
6.17 Aug 01, 2017: GenMark Reports Second Quarter 2017 Results 168
6.18 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017 169
6.19 Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 172
6.20 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 175
6.21 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 177
6.22 Jul 18, 2017: LabCorp's William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 179
6.23 Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 180
6.24 Jun 29, 2017: MedMira Reports FY2017 Third Quarter Results 180
6.25 Jun 22, 2017: OraSure Technologies Appoints Mara G. Aspinall to Board of Directors 180
6.26 Jun 21, 2017: Dr. Helge Lubenow elected as a new member to the Board of Directors 181
6.27 Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 181
6.28 Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results 182
6.29 Jun 08, 2017: Enzo Biochem Reports Increased Revenues, Improved Operating Results 182
6.30 Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results 184
6.31 May 22, 2017: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results 185
6.32 May 22, 2017: Alere Provides Preliminary Unaudited Financial Results 186
6.33 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 187
6.34 May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results 188
6.35 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 189
6.36 May 09, 2017: OPKO Health Reports 2016 Financial and Operating Results 190
6.37 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 191
6.38 May 03, 2017: OraSure Announces 2017 First Quarter Financial Results 193
6.39 May 02, 2017: GenMark Diagnostics Reports First Quarter 2017 Results 194
6.40 May 02, 2017: QIAGEN reports results for first quarter 2017 195
6.41 Apr 25, 2017: Laboratory Corporation of America Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance 197
6.42 Apr 21, 2017: Covance to Expand Large-Molecule Development Capabilities in the UK 199
6.43 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review 200
6.44 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 202
6.45 Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 205
6.46 Apr 06, 2017: Vela Diagnostics Receives CE-IVD for HBV Quantitative PCR Test 206
6.47 Mar 31, 2017: MedMira Reports FY2017 Second Quarter Results 206
6.48 Mar 31, 2017: Company Founder and Analytik Jena Executive Board Member Klaus Berka Steps Down from the Operational Business 207
6.49 Mar 30, 2017: Genedrive: Interim Results for the six month period to 31 December 2016 207
6.50 Mar 29, 2017: LabCorp Promotes Executive Gary Huff to CEO of LabCorp Diagnostics, One of the Company's Two Primary Business Segments 208
6.51 Mar 27, 2017: Mobidiag Pursues its Growth with New Offices in United Kingdom and Appoints Stuart Cranmer as Managing Director 209
6.52 Mar 20, 2017: Siemens Healthineers Receives FDA Premarket Approval of HCV Genotyping Test for Hepatitis C Patients 209
6.53 Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results 210
6.54 Mar 13, 2017: Enzo Biochem Reports Increased Second Quarter Operating Results 211
6.55 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 212
6.56 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 213
6.57 Mar 09, 2017: Alere Provides Update on Arriva Medical 214
6.58 Mar 03, 2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development 215
6.59 Mar 01, 2017: OPKO Health Reports 2016 Financial and Operating Results 215
6.60 Mar 01, 2017: bioMerieux - 2016 Financial Results 216
7 Appendix 287
7.1 Methodology 287
7.2 About GlobalData 290
7.3 Contact Us 290
7.4 Disclaimer 290

1.1 List of Tables
Table 1: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Stage of Development 16
Table 2: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Territory 17
Table 3: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Regulatory Path 18
Table 4: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Estimated Approval Date 19
Table 5: Hepatitis Viruses Diagnostic Tests - Ongoing Clinical Trials 20
Table 6: Hepatitis Viruses Diagnostic Tests Companies - Pipeline Products by Stage of Development 21
Table 7: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Stage of Development 24
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 28
Table 9: ARCHITECT c16000 System - HbSAg Assay - Product Status 28
Table 10: ARCHITECT c16000 System - HbSAg Assay - Product Description 28
Table 11: ARCHITECT c4000 System - HbSAg Assay - Product Status 29
Table 12: ARCHITECT c4000 System - HbSAg Assay - Product Description 29
Table 13: ARCHITECT c8000 System - HbSAg Assay - Product Status 29
Table 14: ARCHITECT c8000 System - HbSAg Assay - Product Description 29
Table 15: ARCHITECT ci16200 Integrated System - HbSAg Assay - Product Status 30
Table 16: ARCHITECT ci16200 Integrated System - HbSAg Assay - Product Description 30
Table 17: ARCHITECT ci4100 Integrated System - HbSAg Assay - Product Status 30
Table 18: ARCHITECT ci4100 Integrated System - HbSAg Assay - Product Description 30
Table 19: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 20: RosGENE For Hepatitis - Product Status 31
Table 21: RosGENE For Hepatitis - Product Description 31
Table 22: Alderon Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 23: eSystem - Qualitative HCV RNA Assay - Product Status 32
Table 24: eSystem - Qualitative HCV RNA Assay - Product Description 32
Table 25: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 26: Diagnostic Test - Hepatitis B/C - Product Status 33
Table 27: Diagnostic Test - Hepatitis B/C - Product Description 33
Table 28: Aptus Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 34
Table 29: AptaDetect-HCV - Product Status 34
Table 30: AptaDetect-HCV - Product Description 34
Table 31: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 32: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Status 35
Table 33: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Description 35
Table 34: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Status 36
Table 35: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Description 36
Table 36: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 37
Table 37: Multiplexed Detection - Anti-HCV Antibodies - Product Status 37
Table 38: Multiplexed Detection - Anti-HCV Antibodies - Product Description 37
Table 39: BCR Corp Pipeline Products & Ongoing Clinical Trials Overview 38
Table 40: Disposable Biosensor Device - HCV - Product Status 38
Table 41: Disposable Biosensor Device - HCV - Product Description 38
Table 42: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 43: DxN VERIS HBV Assay - Product Status 39
Table 44: DxN VERIS HBV Assay - Product Description 39
Table 45: DxN VERIS HCV Assay - Product Status 40
Table 46: DxN VERIS HCV Assay - Product Description 40
Table 47: UniCel DxN - HCV Viral Load Test - Product Status 40
Table 48: UniCel DxN - HCV Viral Load Test - Product Description 40
Table 49: VERIS HBV Assay - Product Status 41
Table 50: VERIS HBV Assay - Product Description 41
Table 51: Beckman Coulter Inc - Ongoing Clinical Trials Overview 42
Table 52: DxN VERIS HBV Assay - Clinical Utility of the DxN HBV Assay as an Aid in the Management of HBV-infected Individuals Undergoing Antiviral Therapy 43
Table 53: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview 44
Table 54: BIO-FLASH anti-HBe Assay - Product Status 44
Table 55: BIO-FLASH anti-HBe Assay - Product Description 44
Table 56: BIO-FLASH HAV Assay - Product Status 45
Table 57: BIO-FLASH HAV Assay - Product Description 45
Table 58: BIO-FLASH HBe Ag Assay - Product Status 45
Table 59: BIO-FLASH HBe Ag Assay - Product Description 46
Table 60: Biomagnetics Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
Table 61: Diagnostic Test - Hepatitis B - Product Status 47
Table 62: Diagnostic Test - Hepatitis B - Product Description 47
Table 63: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 64: BioPlex 2200 - Hepatitis Test - Product Status 48
Table 65: BioPlex 2200 - Hepatitis Test - Product Description 48
Table 66: BioPlex 2200 - HIV/Hep Screening - Product Status 49
Table 67: BioPlex 2200 - HIV/Hep Screening - Product Description 49
Table 68: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 69: AFIAS-6 - Anti-HBs Test - Product Status 50
Table 70: AFIAS-6 - Anti-HBs Test - Product Description 51
Table 71: AFIAS-6 - HBsAg Test - Product Status 51
Table 72: AFIAS-6 - HBsAg Test - Product Description 51
Table 73: ichroma Test - Anti-HBs - Product Status 51
Table 74: ichroma Test - Anti-HBs - Product Description 52
Table 75: ichroma Test - HBsAg - Product Status 52
Table 76: ichroma Test - HBsAg - Product Description 52
Table 77: ichroma Test - HCV - Product Status 52
Table 78: ichroma Test - HCV - Product Description 53
Table 79: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54
Table 80: Diagnostic Test - Hepatitis C - Product Status 54
Table 81: Diagnostic Test - Hepatitis C - Product Description 54
Table 82: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 55
Table 83: Xpert HBV Viral Load Assay - Product Status 55
Table 84: Xpert HBV Viral Load Assay - Product Description 55
Table 85: Xpert HCV Quant Assay - Product Status 56
Table 86: Xpert HCV Quant Assay - Product Description 56
Table 87: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
Table 88: Diagnostic Assay - HCVA - Product Status 57
Table 89: Diagnostic Assay - HCVA - Product Description 57
Table 90: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
Table 91: HCV RNA Real-time PCR Kit - Product Status 58
Table 92: HCV RNA Real-time PCR Kit - Product Description 58
Table 93: Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 59
Table 94: Diagnostic Test - Hepatitis C - Product Status 59
Table 95: Diagnostic Test - Hepatitis C - Product Description 59
Table 96: Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
Table 97: Real Time PCR Kit - HAV - Product Status 60
Table 98: Real Time PCR Kit - HAV - Product Description 60
Table 99: Real Time PCR Kit - HEV - Product Status 61
Table 100: Real Time PCR Kit - HEV - Product Description 61
Table 101: Real Time PCR Kit - HGV - Product Status 61
Table 102: Real Time PCR Kit - HGV - Product Description 62
Table 103: Real Time PCR Kit - HGV-LC - Product Status 62
Table 104: Real Time PCR Kit - HGV-LC - Product Description 62
Table 105: Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 63
Table 106: SAS - Hepatitis-C Assay - Product Status 63
Table 107: SAS - Hepatitis-C Assay - Product Description 63
Table 108: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 64
Table 109: Diagnostic Assay - HBsAg High Throughput - Product Status 64
Table 110: Diagnostic Assay - HBsAg High Throughput - Product Description 65
Table 111: Diagnostic Assay - HCV II - Product Status 65
Table 112: Diagnostic Assay - HCV II - Product Description 65
Table 113: LIAISON - Anti-HDV Assay - Product Status 65
Table 114: LIAISON - Anti-HDV Assay - Product Description 66
Table 115: LIAISON XL - Hepatitis A Assay - Product Status 66
Table 116: LIAISON XL - Hepatitis A Assay - Product Description 66
Table 117: LIAISON XL - Hepatitis B Assay - Product Status 67
Table 118: LIAISON XL - Hepatitis B Assay - Product Description 67
Table 119: LIAISON XL - Hepatitis C Assay - Product Status 67
Table 120: LIAISON XL - Hepatitis C Assay - Product Description 68
Table 121: D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 69
Table 122: HCV Nanogold Assay - Product Status 69
Table 123: HCV Nanogold Assay - Product Description 69
Table 124: DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
Table 125: USB-stick Based Hepatitis Test - Product Status 70
Table 126: USB-stick Based Hepatitis Test - Product Description 70
Table 127: Ecoli s.r.o. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 128: AmpliSens HBV-Eph PCR Kit - Product Status 71
Table 129: AmpliSens HBV-Eph PCR Kit - Product Description 72
Table 130: AmpliSens HBV-FEP PCR Kit - Product Status 72
Table 131: AmpliSens HBV-FEP PCR Kit - Product Description 72
Table 132: AmpliSens HBV-FRT PCR Kit - Product Status 73
Table 133: AmpliSens HBV-FRT PCR Kit - Product Description 73
Table 134: AmpliSens HBV-Monitor-FRT PCR Kit - Product Status 73
Table 135: AmpliSens HBV-Monitor-FRT PCR Kit - Product Description 74
Table 136: AmpliSens HBV/HDV-FRT PCR Kit - Product Status 74
Table 137: AmpliSens HBV/HDV-FRT PCR Kit - Product Description 74
Table 138: AmpliSens HCV-1/2/3-FEP PCR Kit - Product Status 75
Table 139: AmpliSens HCV-1/2/3-FEP PCR Kit - Product Description 75
Table 140: AmpliSens HCV-1/2/3-FRT PCR Kit - Product Status 75
Table 141: AmpliSens HCV-1/2/3-FRT PCR Kit - Product Description 76
Table 142: AmpliSens HCV-Eph PCR Kit - Product Status 76
Table 143: AmpliSens HCV-Eph PCR Kit - Product Description 76
Table 144: AmpliSens HCV-FEP PCR Kit - Product Status 77
Table 145: AmpliSens HCV-FEP PCR Kit - Product Description 77
Table 146: AmpliSens HCV-FRT PCR Kit - Product Status 77
Table 147: AmpliSens HCV-FRT PCR Kit - Product Description 78
Table 148: AmpliSens HCV-Genotype-EPh PCR Kit - Product Status 78
Table 149: AmpliSens HCV-Genotype-EPh PCR Kit - Product Description 78
Table 150: AmpliSens HCV-Genotype-FRT PCR Kit - Product Status 79
Table 151: AmpliSens HCV-Genotype-FRT PCR Kit - Product Description 79
Table 152: AmpliSens HCV-Monitor-FRT PCR Kit - Product Status 79
Table 153: AmpliSens HCV-Monitor-FRT PCR Kit - Product Description 80
Table 154: AmpliSens HDV-FEP PCR Kit - Product Status 80
Table 155: AmpliSens HDV-FEP PCR Kit - Product Description 80
Table 156: AmpliSens HDV-FRT PCR Kit - Product Status 81
Table 157: AmpliSens HDV-FRT PCR Kit - Product Description 81
Table 158: AmpliSens HDV-Monitor-FRT PCR kit - Product Status 81
Table 159: AmpliSens HDV-Monitor-FRT PCR kit - Product Description 81
Table 160: Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview 82
Table 161: AmpiProbe HBV Viral Load Assay - Product Status 82
Table 162: AmpiProbe HBV Viral Load Assay - Product Description 82
Table 163: Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 83
Table 164: FTD HBV-Delta Quantification Assay - Product Status 83
Table 165: FTD HBV-Delta Quantification Assay - Product Description 83
Table 166: FTD HCV Genotyping Assay - Product Status 84
Table 167: FTD HCV Genotyping Assay - Product Description 84

1.2 List of Figures
Figure 1: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Stage of Development 16
Figure 2: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Territory 17
Figure 3: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Regulatory Path 18
Figure 4: Hepatitis Viruses Diagnostic Tests - Pipeline Products by Estimated Approval Date 19
Figure 5: Hepatitis Viruses Diagnostic Tests - Ongoing Clinical Trials 20
Filed in: In Vitro Diagnostic, Medical Device
Publisher : GlobalData